Journal
NATURE REVIEWS CANCER
Volume 3, Issue 8, Pages 615-622Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc1147
Keywords
-
Categories
Ask authors/readers for more resources
Colorectal cancer (CRC) is the second most common type of malignancy in Western nations. Improvements in surgical and radiotherapeutic techniques and the increased availability of new cytotoxic drugs have improved outcome, but 50% of patients still die from recurrent or metastatic disease. Several features of its natural history render CRC a good candidate for gene therapy. Techniques include gene replacement, virus-directed enzyme-prodrug therapy, immune manipulation and virotherapy, all of which have entered clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available